I am a
Home I AM A Search Login

Papers of the Week

2020 May 29

Br J Clin Pharmacol

Ferric citrate in the management of hyperphosphatemia and iron deficiency anemia: A meta-analysis in patients with chronic kidney disease.


Phosphate-lowering effects of ferric citrate were reported in several clinical trials, but mostly in small-scale studies. The aim of this meta-analysis was to investigate the efficacy and safety of ferric citrate in controlling hyperphosphatemia and iron-deficiency anemia in chronic kidney disease (CKD) patients.